BackRapport Therapeutics Overview

Rapport Therapeutics Current Assets

Track Rapport Therapeutics's current assets ($480M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$484.69M
66.58% YoYΔ $193.73M vs prior year quarter

Peer average

Loading

Rapport Therapeutics Current Assets History

Loading

Rapport Therapeutics vs. peers: Current Assets Comparison

Loading

Rapport Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rapport Therapeutics (RAPP) FAQ

As of the most recent data (March 2026), RAPP shows a current assets of $480M. That compares with $290M in the prior-year period — up 66.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RAPP's current assets is now $480M (was $290M) — a 66.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Rapport Therapeutics is outperforming or lagging.

Tracking RAPP's current assets over time shows whether Rapport Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $480M That compares with $290M in the prior-year period — up 66.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Rapport Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $480M) with ownership activity and broader fundamentals.